Cassava Sciences Inc. (SAVA)
NASDAQ (CM) 
SAVA Stock Plunges as Cassava Sciences CEO Steps Down. What to Know.
A bad month just got much worse for Cassava Sciences (NASDAQ: SAVA ). SAVA stock is plunging today on news that President and CEO Remi Barbier is stepping down, effective immediately.
Why Cassava Sciences Stock Is Sinking Today
A former consultant to Cassava was indicted for alleged fraud related to NIH grants. Cassava received some federal funding related to these grants.
Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation
Cassava Sciences SAVA has engaged the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC) amid ongoing investigations into the company and two senior employees.
SAVA Stock Alert: Former Cassava Science Advisor Charged With Fraud
Shares of Cassava Sciences (NASDAQ: SAVA ), which has an Alzheimer's drug candidate called simufilam, fell 35% on June 28 and another 13% over the weekend. This move in SAVA stock comes after a key science advisor was charged with defrauding the National Institutes of Health (NIH).
Cassava Sciences shares fall after onetime advisor indicted on fraud charges
Shares of biotech company Cassava Sciences Inc. plummeted on Friday after a federal grand jury indicted a onetime science advisor to Cassava and charged him with falsifying data to obtain millions of dollars in government funds — the latest drama for a company that has faced questions over its efforts to develop an experimental Alzheimer's disease drug.
Cassava Sciences Shares Plunge on Indictment Against Former Advisor
A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.
2 Stocks Under $20 for Investors to Watch
This week in Cheap Seats: Stocks Under $20 segment, we're taking a look at two stocks presenting an interesting buying opportunity: Cassava Sciences Inc (NASDAQ:SAVA) and Vale SA (NYSE:VALE).
Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright After Key Golden Cross
After reaching an important support level, Cassava Sciences, Inc. (SAVA) could be a good stock pick from a technical perspective. SAVA recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
